Avelios Medical
Germany
- Munich
- 07/02/2025
- Series A
- $31,144,050
Avelios offers a state-of-the-art HIS of the future: Treatment process-oriented digitization, a modular microservices platform & fully structured data.
With Avelios you treat more patients - better!
The fully modular Avelios software platform digitizes and optimizes all hospital workflows in a user-friendly way. In doing so, the highly innovative software additionally generates fully structured treatment data in an automated manner and enables data-driven research, business intelligence, workflow automation and the development & integration of unique AI algorithms.
Our goal is to enable first-class patient care for everyone!
At Avelios creativity and smart thinking is at the core of our work. We are constantly stepping outside of our comfort zone to stay ahead and deliver outstanding results to our customers every day. Our clear goal is to be a leading software company in the healthcare sector and our motivated colleagues make the difference on our way to achieve that.
- Industry Software Development
- Website https://en.avelios.com/
- LinkedIn https://www.linkedin.com/company/avelios-medical/
Navier AI | $6,500,000 | (Dec 17, 2025)
AIR Platforms | $6,100,000 | (Dec 17, 2025)
Auxira Health | $7,800,000 | (Dec 17, 2025)
Mirelo AI | $41,000,000 | (Dec 17, 2025)
Lucis (YC X25) | $8,500,000 | (Dec 17, 2025)
Verisoul | $8,800,000 | (Dec 17, 2025)
Aeovian Pharmaceuticals | $55,000,000 | (Dec 17, 2025)
Nanit | $50,000,000 | (Dec 17, 2025)
Culture Biosciences | Undisclosed Amount | (Dec 17, 2025)
YSE Beauty | $15,000,000 | (Dec 17, 2025)
Vital Lyfe | $24,000,000 | (Dec 17, 2025)
Dux Security | $9,000,000 | (Dec 17, 2025)